Upgrade to SI Premium - Free Trial

Organon (OGN)

13.75 -0.01 (0.07%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/29/26)

Latest Headlines

Altius Provides 3rd Quarter 2026 Project Generation Update October 19, 2026 7:49 AM - BizWire Organon to Report Third Quarter 2026 Results in Its Regularly Scheduled Form 10-Q Filing October 19, 2026 7:30 AM - BizWire Organon's hormone-free IUD shows efficacy through 6 years in trial October 16, 2026 7:30 AM - StreetInsider Organon Announces Positive Interim Phase 3 Study Results for MIUDELLA®, a Hormone-Free, Intrauterine Device (IUD), Through 6 Years of Use to Be Presented at the 2026 Society of Family Planning Annual October 16, 2026 7:30 AM - BizWire Orogen Royalties agrees to sell Wyoming copper-gold project to Seabridge October 13, 2026 8:01 AM - StreetInsider Orogen Royalties Enters into Agreement to Sell the Slaughterhouse Copper-Gold Project to Seabridge Gold October 13, 2026 8:01 AM - StreetInsider Orogen Royalties Creates a Royalty on the Cibola Copper-Gold Project in British Columbia October 8, 2026 8:00 AM - StreetInsider Organon to Present New Real-World Analysis of VTAMA® (tapinarof) Cream, 1%, at the 2026 Fall Clinical Dermatology Conference October 1, 2026 8:00 AM - BizWire FDA accepts review of application to extend Miudella IUD use to 6 years September 14, 2026 7:30 AM - StreetInsider Organon Announces US FDA Has Accepted for Review a Supplemental New Drug Application for MIUDELLA®, a Hormone-Free Intrauterine Device September 14, 2026 7:30 AM - BizWire Orogen Royalties acquires undrilled Nevada gold project September 10, 2026 7:31 AM - StreetInsider Orogen Royalties Acquires the Serpent Gold Project in Nevada September 10, 2026 7:31 AM - StreetInsider Orogen Royalties acquires two Utah gold projects with Triple Flag September 2, 2026 8:01 AM - StreetInsider Orogen Royalties Acquires Two Gold Projects in Southwest Utah September 2, 2026 8:01 AM - StreetInsider National Can-RISE Study to Help Close Critical Gaps in Menopause Research August 27, 2026 9:00 AM - Globe NewsWire Form 4 Organon & Co. For: Aug 11 Filed by: Arjona Ferreira Juan Camilo August 12, 2026 1:02 PM - SEC Filing Organon opens REMS enrollment for copper IUD ahead of late 2026 launch August 11, 2026 7:31 AM - StreetInsider Organon Opens REMS Program for MIUDELLA® Ahead of Anticipated Commercial Availability August 11, 2026 7:30 AM - BizWire Form 4 Organon & Co. For: Aug 05 Filed by: Drinane Juliana Papa August 5, 2026 4:05 PM - SEC Filing Organon Announces Quarterly Dividend July 31, 2026 8:30 AM - BizWire Organon (OGN) Declares $0.02 Quarterly Dividend; 0.6% Yield July 31, 2026 8:30 AM - StreetInsider Organon presents tapinarof cream data across age groups at SPD meeting July 24, 2026 8:00 AM - StreetInsider New Analysis of Phase 3 Pooled Data for Organon’s VTAMA® (tapinarof) cream, 1%, Demonstrates Early, Consistent Improvements in Atopic Dermatitis Patients Across Pediatric Age Groups and in Adults¹ July 24, 2026 8:00 AM - BizWire Full Article List